These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 20809175

  • 41. Significance of aggressive surgery for an invasive carcinoma derived from an intraductal papillary mucinous neoplasm diagnosed preoperatively as borderline resectable.
    Aimoto T, Mizutani S, Kawano Y, Suzuki H, Uchida E.
    J Nippon Med Sch; 2013; 80(5):371-7. PubMed ID: 24189355
    [Abstract] [Full Text] [Related]

  • 42. Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors.
    Passot G, Lebeau R, Hervieu V, Ponchon T, Pilleul F, Adham M.
    Pancreas; 2012 Jan; 41(1):137-41. PubMed ID: 22076564
    [Abstract] [Full Text] [Related]

  • 43. A case of minimally invasive intraductal papillary mucinous carcinoma resected after 17-year follow-up.
    Oguro S, Esaki M.
    Jpn J Clin Oncol; 2011 Sep; 41(9):1152. PubMed ID: 21875939
    [No Abstract] [Full Text] [Related]

  • 44. Branch duct intraductal papillary mucinous neoplasm of the pancreas in solid organ transplant recipients.
    Gill KR, Pelaez-Luna M, Keaveny A, Woodward TA, Wallace MB, Chari ST, Smyrk TC, Takahashi N, Clain JE, Levy MJ, Pearson RK, Petersen BT, Topazian MD, Vege SS, Kendrick M, Farnell MB, Raimondo M.
    Am J Gastroenterol; 2009 May; 104(5):1256-61. PubMed ID: 19352341
    [Abstract] [Full Text] [Related]

  • 45. Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies.
    Yogi T, Hijioka S, Imaoka H, Mizuno N, Hara K, Tajika M, Tanaka T, Ishihara M, Shimizu Y, Hosoda W, Yatabe Y, Niwa Y, Yoshimura K, Bhatia V, Fujita J, Yamao K.
    J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):757-65. PubMed ID: 26148131
    [Abstract] [Full Text] [Related]

  • 46. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance.
    Kang MJ, Jang JY, Lee KB, Chang YR, Kwon W, Kim SW.
    Ann Surg; 2014 Aug; 260(2):356-63. PubMed ID: 24378847
    [Abstract] [Full Text] [Related]

  • 47. Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.
    Takeshita A, Kimura W, Hirai I, Takasu N, Moriya T, Tezuka K, Watanabe T.
    Pancreas; 2012 Jan; 41(1):114-20. PubMed ID: 22143341
    [Abstract] [Full Text] [Related]

  • 48. Conditional survival analysis for patients with intraductal papillary mucinous neoplasms (IPMNs) undergoing curative resection.
    Gaitanidis A, Alevizakos M, Tsaroucha A, Tsalikidis C, Simopoulos C, Pitiakoudis M.
    Eur J Surg Oncol; 2018 May; 44(5):693-699. PubMed ID: 29426780
    [Abstract] [Full Text] [Related]

  • 49. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
    Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, Barthet M, O'Toole D, Rufat P, Partensky C, Cuillerier E, Lévy P, Belghiti J, Ruszniewski P.
    Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN.
    Yamaguchi K, Kanemitsu S, Hatori T, Maguchi H, Shimizu Y, Tada M, Nakagohri T, Hanada K, Osanai M, Noda Y, Nakaizumi A, Furukawa T, Ban S, Nobukawa B, Kato Y, Tanaka M.
    Pancreas; 2011 May; 40(4):571-80. PubMed ID: 21499212
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
    Ishida M, Egawa S, Aoki T, Sakata N, Mikami Y, Motoi F, Abe T, Fukuyama S, Sunamura M, Unno M, Moriya T, Horii A, Furukawa T.
    Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas.
    Hibi Y, Fukushima N, Tsuchida A, Sofuni A, Itoi T, Moriyasu F, Mukai K, Aoki T.
    Pancreas; 2007 Mar; 34(2):197-204. PubMed ID: 17312458
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.